Bipolar Disorder in Late Life
- Describe at least two important considerations in choosing medications for patients with bipolar disorder as they age.
- Give at least two examples of disorders other than bipolar disorder in the differential diagnosis of patients over age sixty with episodes that may be indicative of bipolar disorder.
- Discuss common comorbidities in patients with bipolar disorder as they age.
Rebecca Lundquist, MD
Director, Psychiatric Residency Program, Broadlawns Medical Center
Dr. Lundquist does not have a financial relationship to disclose but does intend to discuss off-label uses of commercial products/devices. Additionally, Dr. Lundquist's spouse was employed as a research scientist by Novartis through the end of March 2019.
Date of original release: October 4, 2019
Most recent review/update: October 4, 2019
Termination date: October 23, 2020
Continuing Education Credit
- MD: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Iowa Medical Society (IMS). Des Moines University (DMU) is accredited by IMS to provide continuing medical education for physicians. DMU designates this enduring materials activity for a maximum of 0.50 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
- DO: Des Moines University (DMU) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians. DMU designates this program for a maximum of 0.50 AOA Category 2-B credits and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.
- Other Healthcare Professionals: This enduring materials activity is designated for a maximum of 0.50 AMA PRA Category 1 Credit(s)™.
No commercial interest company provided financial support for this continuing education activity.
Everyone in a position to control the content of this educational activity will disclose to the CME provider and to attendees all relevant financial relationships with any commercial interest. They will also disclose if any pharmaceuticals or medical procedures and devices discussed are investigational or unapproved for use by the U.S. Food and Drug Administration (FDA). Determination of educational content and the selection of speakers is the responsibility of the activity director. Firms providing financial support did not have input in these areas. The information provided at this CME activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The content of each presentation does not necessarily reflect the views of Des Moines University.
- 0.50 AMA PRA Category 1 Credits™
- 0.50 AOA Category 2B
- 0.50 CE Contact Hour(s)